Teva Pharmaceutical Industries Ltd. — Earnings Release 2004

Feb 15, 2005

C001	��� ������ ��������� ��"�		2
Public	TEVA- PHARMACEUTICAL INDUSTRIES LTD.
	2529	Corporation no: 520013954
	Stock Exchange/Market: ���
	310
	379	P.O.B 3190 , Petach Tikva 49131 , ,
	Tel: 03-9267297 , 03-9267281 Fax: 03-9267429
	E.mail address: DORIT@TEVA.CO.IL	Date of transmission: 15/02/2005
		Time of broadcast: 07:43 07:12:52
		Reference: 2005-02-011473

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Report of Periodic or Interim ReportRegulation 3 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
TEVA REPORTS RECORD SALES AND NET INCOME FOR Q4 2004
Q404PRfinalcombined150205_isa.pdf

Please find attached a press release and its non-binding hebrew translation, provided for convenience purposes only
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous name of reporting entity:
Date of revision of form structure: 20/01/2005
- - -
Name of the Signatory : Suesskind Dan Position of Signatory in the reporting corporation: Chief Financial Officer
Basel Telephone: 02-5892840 , Facsimile: 02-5892839 , E-mail: dan.suesskind@teva.co.il